Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
about
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarctionEmbolic protection devices in saphenous vein graft and native vessel percutaneous intervention: a reviewManagement of Percutaneous Coronary Intervention Complications.Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction.Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarctionProstaglandin E1 protects coronary microvascular function via the glycogen synthase kinase 3β-mitochondrial permeability transition pore pathway in rat hearts subjected to sodium laurate-induced coronary microembolization.Predicting coronary no-reflow in patients with acute ST-segment elevation myocardial infarction using Bayesian approaches.Novel antibody against a glutamic acid-rich human fibrinogen-like protein 2-derived peptide near Ser91 inhibits hfgl2 prothrombinase activityLoss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patientsThrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodelingPrognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance.A case of successful reperfusion through a combination of intracoronary thrombolysis and aspiration thrombectomy in ST-segment elevation myocardial infarction associated with an ectatic coronary artery.A Practical Method for No-Reflow Treatment.Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial.The optimal time of B-type natriuretic peptide sampling associated with post-myocardial infarction remodelling after primary percutaneous coronary intervention.Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.Efficacy of combination treatment with intracoronary abciximab and aspiration thrombectomy on myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary coronary stenting.No-reflow phenomenon: maintaining vascular integrity.Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy.Invasive measurement of coronary microvascular resistance in patients with acute myocardial infarction treated by primary PCI.ST elevation myocardial infarction: recent advances and updates.Myocardial protection from ischemia-reperfusion injury post coronary revascularization.Predictive value of plaque morphology assessed by frequency-domain optical coherence tomography for impaired microvascular perfusion after elective stent implantation: the intracoronary electrocardiogram study.Effect of Thrombus Composition and Viscosity on Sonoreperfusion Efficacy in a Model of Micro-Vascular Obstruction.Predictors of Intramyocardial Hemorrhage After Reperfused ST-Segment Elevation Myocardial Infarction.The Role of Nitric Oxide during Sonoreperfusion of Microvascular Obstruction.Coronary vasomotor function in infarcted and remote myocardium after primary percutaneous coronary intervention.Ischaemia-reperfusion injury impairs tissue plasminogen activator release in man.Thrombus aspiration in STEMI revisited: impact on coronary microcirculation?Link between aortic valve sclerosis and myocardial no-reflow in ST-segment elevation myocardial infarction.Assessment of microembolization associated with revascularization in acute myocardial infarction: MDCT cardiac perfusion and function study.Predicting coronary no-reflow in patients with acute myocardial infarction.Successful prevention of no-reflow phenomenon in a high-risk patient using excimer laser coronary atherectomy.MRI quantification of left ventricular function in microinfarct versus large infarct in swine model.MRI monitoring of function, perfusion and viability in microembolized moderately ischemic myocardium.Left circumflex coronary artery is protected against no-reflow phenomenon following percutaneous coronary intervention for coronary artery disease.Perforated balloon technique: A simple and handy technique to combat no-reflow phenomenon in coronary system.Immediate versus deferred stenting for patients undergoing primary or emergent percutaneous coronary intervention: Protocol for a systematic review and meta-analysis.Ripk3 induces mitochondrial apoptosis via inhibition of FUNDC1 mitophagy in cardiac IR injury.Assessment of the acute effects of glucocorticoid treatment on coronary microembolization using cine, first-pass perfusion, and delayed enhancement MRI.
P2860
Q26740252-4DDCF123-61C6-43DB-A0D4-2633E8E0A78FQ26851837-62ACB5C0-6D09-4796-940E-D9CE92AFC40DQ30400083-29193AFB-7669-47AE-A398-4DB571061CA5Q30409710-3356F8FF-ACDC-4DCD-96A8-9D7935C0D486Q33718246-2EFC13D3-F39E-46EC-B3CE-26BCB21025E7Q33733272-BC67E625-8497-4BB5-B556-1BF6FE411441Q34463125-171E1676-03A1-4069-A9BF-F0F8DBB57972Q35146839-0DAC96C1-8CC0-4C8B-A44A-50CDE770DBDBQ35654597-4DBE0774-2945-4746-B645-87F1041E24E1Q35887746-F9DED7B1-4C40-4ECC-9928-DEC4DF6701E1Q36288870-D8BACC5D-36AD-4ED1-9AB9-0F5EAE83034EQ36337032-6F244B6B-B948-4089-BE82-A5D49B7A2166Q36615365-2D0C32CD-96BE-48F9-AE72-2958F2C191C2Q37030536-9EDF0364-007D-4485-8FF3-2E74772E0F8BQ37107870-2757BBD1-80D2-49D5-B42D-C9EFE7D3EB0EQ37140881-D67294DA-8423-4232-BC98-84738E6165C5Q37708215-DFA8CF53-24BA-4489-B3F2-18E38D23E49BQ37912834-5E645F85-BF73-435E-A918-47F3C8BA98F4Q38010782-5C6507A3-E190-4FB0-B20F-C21AE8095975Q38110261-70405A41-AC84-436D-A347-C954D985406DQ38263602-8E630036-9EED-4283-A2A4-5282181543A3Q38552442-E9A71951-13E4-4170-B7CA-4F12F992714DQ38741567-DD08EE21-6CB2-4327-99D1-3F264C09BF71Q39748618-40C53200-9BB5-4812-A037-8503BABD435EQ40061457-4961A5B3-8759-4A2C-BBBE-44CFECD291FEQ41173935-EF891DFD-85B2-4259-A829-0A6B55965700Q41511122-885B3A62-8368-4E4F-AF0A-36A3E037DA94Q42257252-FFBE83C8-327D-42F9-9DFC-06CF4FBE6A69Q42283826-090FCCD3-40A6-4F8C-A5C7-C27A74D18528Q43650709-AC463F50-E3D3-4731-A5E7-C6629FF4583EQ43890787-672A5504-9222-4C65-89CF-E4A31637C67CQ44892298-9FECD4DC-3C74-4DAE-A35F-00D59F2C472DQ45098413-0EA1F171-D004-4005-AAC2-1984650ED5FEQ45278793-9C9E8BF7-A4BF-4012-8C9A-005041E728E1Q45949829-BF9F6A17-A043-42E3-BDEE-7F2451E98BD7Q46260031-F47423A9-C790-40AF-8B92-79B4963A0E58Q48344167-113E153D-B509-47A3-9D1A-DDDD7EB93B2FQ49576775-E220F3C4-0471-448D-AAFC-F92FA04E973EQ50319186-2E923D08-0A60-429A-B0F7-067F420D80F2Q51722839-7EE82F21-E884-4A0B-95E0-6024BA0B6EE7
P2860
Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention and treatment of mi ...... ention: a systematic approach.
@en
Prevention and treatment of mi ...... ention: a systematic approach.
@nl
type
label
Prevention and treatment of mi ...... ention: a systematic approach.
@en
Prevention and treatment of mi ...... ention: a systematic approach.
@nl
prefLabel
Prevention and treatment of mi ...... ention: a systematic approach.
@en
Prevention and treatment of mi ...... ention: a systematic approach.
@nl
P2093
P1476
Prevention and treatment of mi ...... ention: a systematic approach.
@en
P2093
Alexander Dick
Bradley H Strauss
Ronen Jaffe
P304
P356
10.1016/J.JCIN.2010.05.004
P577
2010-07-01T00:00:00Z